Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,582 | 357 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $901.36 | 40 | $0 (2024) |
| GlaxoSmithKline, LLC. | $599.38 | 36 | $0 (2024) |
| Lilly USA, LLC | $536.98 | 24 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $414.67 | 21 | $0 (2023) |
| Merck Sharp & Dohme LLC | $351.13 | 22 | $0 (2023) |
| Novo Nordisk Inc | $340.25 | 18 | $0 (2023) |
| Amgen Inc. | $240.40 | 7 | $0 (2024) |
| Amarin Pharma Inc. | $232.32 | 18 | $0 (2022) |
| Bayer Healthcare Pharmaceuticals Inc. | $221.48 | 12 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $197.90 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $523.42 | 28 | ABBVIE INC. ($93.80) |
| 2023 | $1,720 | 98 | ABBVIE INC. ($314.83) |
| 2022 | $3,036 | 156 | ABBVIE INC. ($409.55) |
| 2021 | $1,302 | 75 | Amarin Pharma Inc. ($159.33) |
All Payment Transactions
357 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.54 | General |
| Category: Inflammation | ||||||
| 12/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: PSYCHIATRY | ||||||
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $20.06 | General |
| Category: RESPIRATORY | ||||||
| 11/25/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Immunology | ||||||
| 11/20/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: GI | ||||||
| 11/18/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: ANTIBIOTIC | ||||||
| 11/06/2024 | Theratechnologies Inc. | EGRIFTA (Drug), TROGARZO | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: HIV | ||||||
| 10/07/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: VIROLOGY | ||||||
| 09/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $19.13 | General |
| Category: Cardio-renal | ||||||
| 09/05/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $18.98 | General |
| 08/09/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: HIV | ||||||
| 08/08/2024 | AstraZeneca Pharmaceuticals LP | LOKELMA (Drug) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/28/2024 | Ardelyx, Inc. | IBSRELA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: GASTROENTEROLOGY | ||||||
| 07/15/2024 | ABBVIE INC. | AVYCAZ (Drug), DALVANCE, TEFLARO | Food and Beverage | In-kind items and services | $25.57 | General |
| Category: ANTI-INFECTIVE | ||||||
| 07/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: VIROLOGY | ||||||
| 07/03/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: VACCINES | ||||||
| 05/23/2024 | Paratek Pharmaceuticals, Inc. | NUZYRA (Drug) | Food and Beverage | In-kind items and services | $24.86 | General |
| Category: ANTIBIOTIC | ||||||
| 05/20/2024 | Cumberland Pharmaceuticals, Inc. | VIBATIV (Drug) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: INFECTIONS AND INFECTIOUS DISEASES | ||||||
| 05/10/2024 | ABBVIE INC. | MAVYRET (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: VIROLOGY | ||||||
| 04/29/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.82 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/26/2024 | Travere Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $7.11 | General |
| 04/24/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: GI | ||||||
| 04/24/2024 | AIMMUNE THERAPEUTICS, INC. | VOWST (Biological) | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: GI | ||||||
| 04/02/2024 | ABBVIE INC. | DALVANCE (Drug), AVYCAZ, TEFLARO | Food and Beverage | In-kind items and services | $18.80 | General |
| Category: ANTI-INFECTIVE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 169 | 195 | $37,112 | $13,644 |
| 2022 | 3 | 244 | 355 | $64,525 | $27,958 |
| 2021 | 4 | 78 | 78 | $26,731 | $8,206 |
| 2020 | 4 | 249 | 255 | $80,775 | $27,066 |
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 65 | 65 | $16,250 | $6,914 | 42.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 61 | 82 | $15,072 | $4,873 | 32.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 43 | 48 | $5,790 | $1,857 | 32.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 105 | 199 | $34,975 | $14,920 | 42.7% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 86 | 86 | $21,500 | $9,605 | 44.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 70 | $8,050 | $3,433 | 42.6% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 24 | 24 | $9,720 | $3,229 | 33.2% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 24 | 24 | $8,856 | $2,839 | 32.1% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 19 | 19 | $5,130 | $1,225 | 23.9% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 11 | 11 | $3,025 | $913.70 | 30.2% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2020 | 93 | 98 | $26,460 | $8,801 | 33.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 63 | 64 | $25,920 | $8,742 | 33.7% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 63 | 63 | $17,325 | $5,852 | 33.8% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 30 | 30 | $11,070 | $3,671 | 33.2% |
About Christina Yeast
Christina Yeast is a Adult Health healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/25/2019. The National Provider Identifier (NPI) number assigned to this provider is 1851952345.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christina Yeast has received a total of $6,582 in payments from pharmaceutical and medical device companies, with $523.42 received in 2024. These payments were reported across 357 transactions from 49 companies. The most common payment nature is "Food and Beverage" ($6,582).
As a Medicare-enrolled provider, Yeast has provided services to 740 Medicare beneficiaries, totaling 883 services with total Medicare billing of $76,875. Data is available for 4 years (2020–2023), covering 14 distinct procedure/service records.
Practice Information
- Specialty Adult Health
- Location Saint Louis, MO
- Active Since 06/25/2019
- Last Updated 05/25/2021
- Taxonomy Code 363LA2200X
- Entity Type Individual
- NPI Number 1851952345
Products in Payments
- QULIPTA (Drug) $512.35
- TRELEGY ELLIPTA (Drug) $406.92
- REXULTI (Drug) $323.28
- MOUNJARO (Drug) $306.73
- UBRELVY (Drug) $262.11
- Vascepa (Drug) $232.32
- Kerendia (Drug) $221.48
- BELSOMRA (Drug) $200.65
- Rybelsus (Drug) $192.01
- XARELTO (Drug) $191.47
- NURTEC ODT (Drug) $167.16
- ADUHELM (Biological) $131.08
- TRULICITY (Drug) $129.28
- TRADJENTA (Drug) $124.07
- TRINTELLIX (Drug) $123.50
- Repatha (Biological) $121.86
- GEMTESA (Drug) $113.56
- CAPLYTA (Drug) $97.44
- SOLIQUA 100/33 (Biological) $96.15
- JARDIANCE (Drug) $95.81
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Adult Health Doctors in Saint Louis
Stephanie Vogel, Np-C, NP-C
Adult Health — Payments: $48,935
Jennifer Speiser, Np, NP
Adult Health — Payments: $14,376
Michele Nobs, N.p, N.P
Adult Health — Payments: $11,208
Allyson Granden, Np-C, NP-C
Adult Health — Payments: $10,285
Marcee Stegemeier, Aprn-Bc, APRN-BC
Adult Health — Payments: $9,559
Heather Popham, Np, NP
Adult Health — Payments: $9,056